Literature DB >> 24844756

Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.

Khalid Mohammed Khan1, Syed Muhammad Saad2, Nimra Naveed Shaikh2, Shafqat Hussain2, Muhammad Imran Fakhri2, Shahnaz Perveen3, Muhammad Taha4, Muhammad Iqbal Choudhary5.   

Abstract

2-Arylquinazolin-4(3H)-ones 1-25 were synthesized by reacting anthranilamide with various benzaldehydes using CuCl2·2H2O as a catalyst in ethanol under reflux. Synthetic 2-arylquinazolin-4(3H)-ones 1-25 were evaluated for their β-glucuronidase inhibitory potential. A trend of inhibition IC50 against the enzyme in the range of 0.6-198.2μM, was observed and compared with the standard d-saccharic acid 1,4-lactone (IC50=45.75±2.16μM). Compounds 13, 19, 4, 12, 14, 22, 23, 25, 15, 8, 17, 11, 21, 1, 3, 18, 9, 2, and 24 with the IC50 values within the range of 0.6-44.0μM, indicated that the compounds have superior activity than the standard. The compounds showed no cytotoxic effects against PC-3 cells. A structure-activity relationship is established.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-Arylquinazolin-4(3H)-ones; Cytotoxicity; Structure–activity relationship; β-Glucuronidase inhibition

Mesh:

Substances:

Year:  2014        PMID: 24844756     DOI: 10.1016/j.bmc.2014.04.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Synthesis, β-glucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids.

Authors:  Obaidurahman Abid; Syahrul Imran; Muhammad Taha; Nor Hadiani Ismail; Waqas Jamil; Syed Muhammad Kashif; Khalid Mohammed Khan; Juliana Yusoff
Journal:  Mol Divers       Date:  2020-04-16       Impact factor: 2.943

Review 2.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

3.  Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors.

Authors:  Maria Yousuf; Nimra Naveed Shaikh; Zaheer Ul-Haq; M Iqbal Choudhary
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

4.  Newly Designed Quinazolinone Derivatives as Novel Tyrosinase Inhibitor: Synthesis, Inhibitory Activity, and Mechanism.

Authors:  Yaru Huang; Jiefang Yang; Yunyang Chi; Chun Gong; Haikuan Yang; Fanxin Zeng; Fang Gao; Xiaoju Hua; Zongde Wang
Journal:  Molecules       Date:  2022-08-29       Impact factor: 4.927

5.  Overcoming Multidrug Resistance (MDR): Design, Biological Evaluation and Molecular Modelling Studies of 2,4-Substituted Quinazoline Derivatives.

Authors:  Laura Braconi; Elisabetta Teodori; Marialessandra Contino; Chiara Riganti; Gianluca Bartolucci; Dina Manetti; Maria Novella Romanelli; Maria Grazia Perrone; Nicola Antonio Colabufo; Stefano Guglielmo; Silvia Dei
Journal:  ChemMedChem       Date:  2022-05-12       Impact factor: 3.540

6.  From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors.

Authors:  Serena Massari; Angela Corona; Simona Distinto; Jenny Desantis; Alessia Caredda; Stefano Sabatini; Giuseppe Manfroni; Tommaso Felicetti; Violetta Cecchetti; Christophe Pannecouque; Elias Maccioni; Enzo Tramontano; Oriana Tabarrini
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.